McClung M - Search Results

1

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards.

Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, McClung M, Morris HA, Silverman S, Trenti T, Wahl DA, Cooper C, Kanis JA; IOF-IFCC Bone Marker Standards Working Group. Vasikaran S, et al. Among authors: mcclung m. Osteoporos Int. 2011 Feb;22(2):391-420. doi: 10.1007/s00198-010-1501-1. Epub 2010 Dec 24. Osteoporos Int. 2011. PMID: 21184054 Review.

2

Diagnosis and management of osteoporosis in postmenopausal women: clinical guidelines. International Committee for Osteoporosis Clinical Guidelines.

Meunier PJ, Delmas PD, Eastell R, McClung MR, Papapoulos S, Rizzoli R, Seeman E, Wasnich RD. Meunier PJ, et al. Among authors: mcclung mr. Clin Ther. 1999 Jun;21(6):1025-44. doi: 10.1016/s0149-2918(99)80022-8. Clin Ther. 1999. PMID: 10440625 Review.

3

Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.

Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kiel D, Felsenberg D, Recker RR, Tonino RP, Roux C, Pinchera A, Foldes AJ, Greenspan SL, Levine MA, Emkey R, Santora AC 2nd, Kaur A, Thompson DE, Yates J, Orloff JJ. Schnitzer T, et al. Among authors: mcclung m. Aging (Milano). 2000 Feb;12(1):1-12. Aging (Milano). 2000. PMID: 10746426 Clinical Trial.

4

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R, Meunier PJ, Reginster JY; Hip Intervention Program Study Group. McClung MR, et al. N Engl J Med. 2001 Feb 1;344(5):333-40. doi: 10.1056/NEJM200102013440503. N Engl J Med. 2001. PMID: 11172164 Free article. Clinical Trial.

5

Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old.

Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P. Boonen S, et al. J Am Geriatr Soc. 2004 Nov;52(11):1832-9. doi: 10.1111/j.1532-5415.2004.52506.x. J Am Geriatr Soc. 2004. PMID: 15507059 Clinical Trial.

6

A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate.

Reginster JY, Felsenberg D, Cooper C, Stakkestad JA, Miller PD, Kendler DL, Adami S, McClung MR, Bolognese MA, Civitelli R, Dumont E, Bonvoisin B, Recker RR, Delmas PD. Reginster JY, et al. Osteoporos Int. 2006 Feb;17(2):159-66. doi: 10.1007/s00198-005-1957-6. Epub 2005 Jun 14. Osteoporos Int. 2006. PMID: 15959614 Review.

7

Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.

Adami S, San Martin J, Muñoz-Torres M, Econs MJ, Xie L, Dalsky GP, McClung M, Felsenberg D, Brown JP, Brandi ML, Sipos A. Adami S, et al. Among authors: mcclung m. Osteoporos Int. 2008 Jan;19(1):87-94. doi: 10.1007/s00198-007-0485-y. Epub 2007 Oct 16. Osteoporos Int. 2008. PMID: 17938984 Clinical Trial.

8

Fracture risk remains reduced one year after discontinuation of risedronate.

Watts NB, Chines A, Olszynski WP, McKeever CD, McClung MR, Zhou X, Grauer A. Watts NB, et al. Among authors: mcclung mr. Osteoporos Int. 2008 Mar;19(3):365-72. doi: 10.1007/s00198-007-0460-7. Epub 2007 Oct 16. Osteoporos Int. 2008. PMID: 17938986 Clinical Trial.

9

Effects of risedronate on fracture risk in postmenopausal women with osteopenia.

Siris ES, Simon JA, Barton IP, McClung MR, Grauer A. Siris ES, et al. Among authors: mcclung mr. Osteoporos Int. 2008 May;19(5):681-6. doi: 10.1007/s00198-007-0493-y. Epub 2007 Oct 30. Osteoporos Int. 2008. PMID: 17968610 Free PMC article.

10

Monthly dosing of 75 mg risedronate on 2 consecutive days a month: efficacy and safety results.

Delmas PD, Benhamou CL, Man Z, Tlustochowicz W, Matzkin E, Eusebio R, Zanchetta J, Olszynski WP, Recker RR, McClung MR. Delmas PD, et al. Among authors: mcclung mr. Osteoporos Int. 2008 Jul;19(7):1039-45. doi: 10.1007/s00198-007-0531-9. Epub 2007 Dec 18. Osteoporos Int. 2008. PMID: 18087660 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters